Company recalls compounded drug products

Jan 03, 2018 - 09:25 AM

PharMEDium Services LLC has recalled 55 lots of compounded drug products due to a lack of sterility assurance, the Food and Drug Administration announced last week. The products were distributed to U.S. hospitals and clinics. Customers with recalled products should immediately quarantine and destroy them, and may report associated adverse reactions or quality problems to the FDA's MedWatch program.

Related News Articles

Headline
Deadline for voluntary hospital readmissions measure extended to Jan. 4
The Centers for Medicare…
Headline
Institute for Diversity and Health Equity names new president and CEO
The AHA’s Institute for Diversity and Health Equity today named Duane Elliott Reynolds as its new president and CEO.
Blog
America’s hospitals continue to share progress and identify ways of further improving care
Axios' The poor state of U.S hospital quality (December 1, 2018) gives an incomplete view on the state of quality and safety in America’s hospitals and health…
Headline
FDA issues revised guidance for outsourcing facilities that compound drugs
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.
Headline
IRFs and LTCHs can review quality data through Jan. 2
Inpatient rehabilitation facilities and long-term care hospitals have until Jan. 2 to review confidential provider reports based on quality data from second-…
Headline
IHI releases paper on board oversight of health system quality
The Institute for Healthcare Improvement today released a white paper intended to help health system boards assess and improve their quality oversight…